Patrizia Borsotti - Search Results

Year	Number of Results
2002	2
2003	1
2004	1
2005	1
2006	2
2009	1
2012	1
2013	1
2014	2
2015	3
2018	1
2019	2
2020	1
2021	1
2023	1
2024	0

1

Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.

Resovi A, Persichitti P, Brunelli L, Minoli L, Borsotti P, Garattini G, Tironi M, Dugnani E, Redegalli M, De Simone G, Pastorelli R, Bani MR, Piemonti L, Mosher DF, Giavazzi R, Taraboletti G, Belotti D. Resovi A, et al. Among authors: borsotti p. J Exp Clin Cancer Res. 2023 Aug 9;42(1):201. doi: 10.1186/s13046-023-02778-y. J Exp Clin Cancer Res. 2023. PMID: 37559126 Free PMC article.

2

Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.

Carminati L, Pinessi D, Borsotti P, Minoli L, Giavazzi R, D'Incalci M, Belotti D, Taraboletti G. Carminati L, et al. Among authors: borsotti p. Carcinogenesis. 2019 Apr 29;40(2):303-312. doi: 10.1093/carcin/bgy177. Carcinogenesis. 2019. PMID: 30544170

3

Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity.

Pinessi D, Resovi A, Sangalli F, Morosi L, Zentilin L, Borsotti P, Carlessi E, Passoni A, Davoli E, Belotti D, Giavazzi R, Giacca M, Valbusa G, Berndt A, Zucchetti M, Taraboletti G. Pinessi D, et al. Among authors: borsotti p. Matrix Biol. 2021 Sep;103-104:22-36. doi: 10.1016/j.matbio.2021.10.001. Epub 2021 Oct 12. Matrix Biol. 2021. PMID: 34653669

4

CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy.

Resovi A, Borsotti P, Ceruti T, Passoni A, Zucchetti M, Berndt A, Riser BL, Taraboletti G, Belotti D. Resovi A, et al. Among authors: borsotti p. Cells. 2020 Apr 13;9(4):952. doi: 10.3390/cells9040952. Cells. 2020. PMID: 32294968 Free PMC article.

5

The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2).

Rusnati M, Borsotti P, Moroni E, Foglieni C, Chiodelli P, Carminati L, Pinessi D, Annis DS, Paiardi G, Bugatti A, Gori A, Longhi R, Belotti D, Mosher DF, Colombo G, Taraboletti G. Rusnati M, et al. Among authors: borsotti p. Angiogenesis. 2019 Feb;22(1):133-144. doi: 10.1007/s10456-018-9644-3. Epub 2018 Aug 30. Angiogenesis. 2019. PMID: 30168023

6

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.

Pinessi D, Ostano P, Borsotti P, Bello E, Guffanti F, Bizzaro F, Frapolli R, Bani MR, Chiorino G, Taraboletti G, Resovi A. Pinessi D, et al. Among authors: borsotti p. Connect Tissue Res. 2015;56(5):355-63. doi: 10.3109/03008207.2015.1045065. Epub 2015 Jun 15. Connect Tissue Res. 2015. PMID: 25943461

7

Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib.

Zucchetti M, Bonezzi K, Frapolli R, Sala F, Borsotti P, Zangarini M, Cvitkovic E, Noel K, Ubezio P, Giavazzi R, D'Incalci M, Taraboletti G. Zucchetti M, et al. Among authors: borsotti p. Cancer Chemother Pharmacol. 2013 Oct;72(4):879-87. doi: 10.1007/s00280-013-2270-2. Epub 2013 Aug 24. Cancer Chemother Pharmacol. 2013. PMID: 23978989

8

Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.

Borsotti P, Ghilardi C, Ostano P, Silini A, Dossi R, Pinessi D, Foglieni C, Scatolini M, Lacal PM, Ferrari R, Moscatelli D, Sangalli F, D'Atri S, Giavazzi R, Bani MR, Chiorino G, Taraboletti G. Borsotti P, et al. Pigment Cell Melanoma Res. 2015 Jan;28(1):73-81. doi: 10.1111/pcmr.12319. Epub 2014 Oct 13. Pigment Cell Melanoma Res. 2015. PMID: 25256553

9

Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies.

Bonezzi K, Belotti D, North BJ, Ghilardi C, Borsotti P, Resovi A, Ubezio P, Riva A, Giavazzi R, Verdin E, Taraboletti G. Bonezzi K, et al. Among authors: borsotti p. Neoplasia. 2012 Sep;14(9):846-54. doi: 10.1593/neo.12728. Neoplasia. 2012. PMID: 23019416 Free PMC article.

10

Potential antagonism of tubulin-binding anticancer agents in combination therapies.

Taraboletti G, Micheletti G, Dossi R, Borsotti P, Martinelli M, Fiordaliso F, Ryan AJ, Giavazzi R. Taraboletti G, et al. Among authors: borsotti p. Clin Cancer Res. 2005 Apr 1;11(7):2720-6. doi: 10.1158/1078-0432.CCR-04-1616. Clin Cancer Res. 2005. PMID: 15814654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year